
Keywords: بیشفعالی; Lisdexamfetamine; d-Amfetamine; Methylphenidate; Modafinil; Drug discrimination; Discriminative effects; Self-administration; Reinforcer; ADHD; attention deficit hyperactivity disorder; AMF; amfetamine; C-II; Schedule 2 Controlled Drug; C-IV; Schedule 4 C